Kenta Nio

424 total citations
28 papers, 169 citations indexed

About

Kenta Nio is a scholar working on Oncology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kenta Nio has authored 28 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Epidemiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kenta Nio's work include Neuroendocrine Tumor Research Advances (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Treatment and Pharmacology (6 papers). Kenta Nio is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Treatment and Pharmacology (6 papers). Kenta Nio collaborates with scholars based in Japan, United States and United Kingdom. Kenta Nio's co-authors include Hiroshi Ariyama, Hitoshi Kusaba, Koichi Akashi, Shuji Arita, Eishi Baba, Yuta Okumura, Michitaka Nakano, Yoshinao Oda, Kenji Tsuchihashi and Kenji Mitsugi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Medicine.

In The Last Decade

Kenta Nio

23 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenta Nio Japan 7 117 39 37 36 35 28 169
Sandipkumar Patel United States 7 190 1.6× 42 1.1× 55 1.5× 35 1.0× 45 1.3× 20 249
Keitaro Shimozaki Japan 10 191 1.6× 25 0.6× 115 3.1× 56 1.6× 22 0.6× 33 257
Tracy Jiezhen Loh Singapore 5 93 0.8× 22 0.6× 66 1.8× 70 1.9× 26 0.7× 9 160
Jennifer Arena Australia 8 173 1.5× 64 1.6× 59 1.6× 61 1.7× 14 0.4× 15 194
Milton Barros Brazil 10 129 1.1× 98 2.5× 75 2.0× 63 1.8× 26 0.7× 43 240
Estelle Cauchin France 10 130 1.1× 40 1.0× 65 1.8× 90 2.5× 13 0.4× 19 234
Maria Cristina Giustiniani Italy 9 89 0.8× 37 0.9× 35 0.9× 156 4.3× 22 0.6× 26 276
Barbara Sosnowska‐Pasiarska Poland 8 94 0.8× 17 0.4× 36 1.0× 14 0.4× 57 1.6× 18 201
Tomoko Norose Japan 8 111 0.9× 64 1.6× 42 1.1× 74 2.1× 9 0.3× 44 187
Keigo Chida Japan 6 138 1.2× 22 0.6× 62 1.7× 52 1.4× 17 0.5× 18 194

Countries citing papers authored by Kenta Nio

Since Specialization
Citations

This map shows the geographic impact of Kenta Nio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenta Nio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenta Nio more than expected).

Fields of papers citing papers by Kenta Nio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenta Nio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenta Nio. The network helps show where Kenta Nio may publish in the future.

Co-authorship network of co-authors of Kenta Nio

This figure shows the co-authorship network connecting the top 25 collaborators of Kenta Nio. A scholar is included among the top collaborators of Kenta Nio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenta Nio. Kenta Nio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nio, Kenta, et al.. (2024). P91-4 A case of immune checkpoint inhibitor-associated myasthenia gravis in advanced breast cancer. Annals of Oncology. 35. S1394–S1394.
2.
Matsumoto, Sayaka, et al.. (2024). A Case of Drug-induced Sweet's Syndrome Caused by Pegfilgrastim. The Nishinihon Journal of Dermatology. 86(6). 575–579.
3.
Komori, Azusa, Satoshi Otsu, Mototsugu Shimokawa, et al.. (2023). Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study. International Journal of Clinical Oncology. 28(8). 1073–1081. 1 indexed citations
4.
5.
6.
Nio, Kenta, Haruo Iguchi, Mototsugu Shimokawa, et al.. (2020). 192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study. Annals of Oncology. 31. S1314–S1314. 1 indexed citations
7.
Otsuka, Taiga, Mototsugu Shimokawa, Satoshi Otsu, et al.. (2019). A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study. Annals of Oncology. 30. iv17–iv18. 5 indexed citations
8.
Nio, Kenta, Kenji Tsuchihashi, Hiroshi Ariyama, et al.. (2018). Successful chemotherapeutic treatment for metastatic littoral cell angioma. Medicine. 97(15). e0378–e0378. 11 indexed citations
9.
Kusaba, Hitoshi, Takeharu Yamanaka, Kenta Nio, et al.. (2018). A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy. Medicine. 97(25). e11042–e11042. 2 indexed citations
10.
Tsuchihashi, Kenji, Kenta Nio, Iori Wada, et al.. (2017). Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction. Medicine. 96(42). e8285–e8285. 4 indexed citations
11.
Tsuchihashi, Kenji, Kenta Nio, Taku Yokoyama, et al.. (2017). Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex. Medicine. 96(49). e8987–e8987. 1 indexed citations
12.
Arita, Shuji, Hiroshi Ariyama, Hitoshi Kusaba, et al.. (2017). Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producing advanced gastric neuroendocrine carcinoma. Oncology Letters. 14(2). 1500–1504. 1 indexed citations
13.
Nio, Kenta, Kenji Tsuchihashi, Hiroshi Ariyama, et al.. (2017). Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report. Molecular and Clinical Oncology. 6(6). 866–870. 18 indexed citations
14.
Tsuchihashi, Kenji, Kenta Nio, Shuji Arita, et al.. (2017). Lingual alveolar soft part sarcoma responsive to pazopanib. Medicine. 96(44). e8470–e8470. 5 indexed citations
15.
Shirakawa, Tsuyoshi, Michitaka Nakano, Kenta Nio, et al.. (2016). Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 27(9). 891–898. 2 indexed citations
16.
Arita, Shuji, Koji Mishima, Mamoru Tanaka, et al.. (2016). Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus. Medicine. 95(29). e4283–e4283. 29 indexed citations
17.
Nio, Kenta, Shuji Arita, Taichi Isobe, et al.. (2015). Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 829–835. 14 indexed citations
18.
Ariyama, Hiroshi, Hitoshi Kusaba, Akihiro Nishie, et al.. (2015). Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report. Oncology Letters. 10(5). 2981–2985. 6 indexed citations
19.
Shirakawa, Tsuyoshi, Michitaka Nakano, Kenta Nio, et al.. (2015). 520P Retrospective analysis of cardiovascular diseases in chemotherapies for advanced solid tumor patients in a single institution. Annals of Oncology. 26. ix156–ix156. 1 indexed citations
20.
Nio, Kenta, Yuta Okumura, Masato Komoda, et al.. (2014). Successful Chemoradiotherapy for Undifferentiated Malignant Neoplasm Arising from the Left Pulmonary Artery. Case Reports in Oncology. 7(2). 484–490. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandipkumar Patel Breakdown of academic impact, for papers by Keitaro Shimozaki Breakdown of academic impact, for papers by Tracy Jiezhen Loh Breakdown of academic impact, for papers by Jennifer Arena Breakdown of academic impact, for papers by Milton Barros Breakdown of academic impact, for papers by Estelle Cauchin Breakdown of academic impact, for papers by Maria Cristina Giustiniani Breakdown of academic impact, for papers by Barbara Sosnowska‐Pasiarska Breakdown of academic impact, for papers by Tomoko Norose Breakdown of academic impact, for papers by Keigo Chida
Rankless by CCL
2026